At the bottom of each article click the “Print & PDF” tab under the “Share this” heading next to the social media tabs (see below). This should link you to a version of the article that is print-friendly.
Guest posting from Dr Catherine Berry, Infectious Diseases Staff Specialist and Antimicrobial Stewardship lead for Hunter New England Health. I’m still recovering from a week of ID on call. It’s intense and we provide service for a huge area of NSW. It’s interesting and challenging trying to see the problem through the referrer’s eyes. Some […]
Here is Josh‘s regular survey – well worth a look! Top ID papers of 2023 Davis
Case load, mortality and relapse Healthcare-associated cases Community acquired cases N=83 (0.9 / 10,000 inpatient bed-days) 8% MRSA 9% Age-adjusted 30-day mortality (c.f. 9% in 2018) Relapse within 15-90 days (2019 – 2022): – 1.8% of adult events – 0% of paediatric events N=264 (2.8 / 10,000 population) 12% MRSA 7% Age-adjusted […]
Collated antibiograms compiled by Dr Rob George, Pathology NSW are now available via the HNE intranet at this location . This is the summary report : Antibiograms_2022_-_HNE_LHD
Presented between November 18-24th : Oral is the New IV presented by Professor Josh Davis and Ms Kristi Kozierowski (AMS pharmacist, John Hunter Hospital): Oral is the New IV_JHH Davis 2023 Oral is the new IV – 2023 – KK Antibiograms presented by Dr Rob George (Microbiologist, Pathology NSW) Are we looking after our antibiotics in Hunter […]
Guest posting from Professors Josh Davis (Hunter New England Health) and Patrick Harris (UQ). AMBLER CLASS Class A Class B Class D Key characteristic Serine group enzyme Metallo-betalactamase OXA-type Key example(s) KPC, GES IMP, NDM, VIM OXA-48. (OXA-181, OXA-232 emerging) Susceptiblity features R to all b-lactams R to all b-lactams except Aztreonam May harbour other […]
Here is Josh’s eclectic selection of top non-COVID papers for 2022! Top ID papers of 2022 Davis Happy New Year all from AIMED.
Here are the presentations from our recent short AMS lectures for AAW! AMS- Who the blood hell are ya? Holly Jordan Jordan AAW Nov22 Overview of AMS at JHH Shorter is Better. Josh Davis Davis Nov22 AAW slides Shorter is better Choosing antibiotics wisely – who really needs ceftriaxone or pip/tazo? John Ferguson Ferguson AAW Nov22 […]
Guest posting from Dr Nicole Organ, Vascular Surgeon, HNE LHD Golden rules Maintain lower limb skin integrity – trauma avoidance, protective routine skin care Treat acute lower limb wounds/skin tears aggressively to prevent chronicity – early use of wound compression Address modifiable risk factors – superficial venous disease, obesity, sedentary lifestyle, arterial disease Use simple […]
How can we control VRE? Ferguson ACIPC 2021 Invited presentation to ACIPC Conference – the top 3 horizontal (standard) controls are: Hand hygiene by healthcare staff Environmental controls – REACH trial Antimicrobial stewardship – target piperacillin+tazobactam and ceftriaxone to reduce usage below 30 DDD/1000 patient-days. References https://www.mja.com.au/journal/2019/211/3/reduced-vre-and-mrsa-colonisation-and-infection-following-sustained-reduction Ferguson- VRE in hospitals – 2014 monograph https://www.publish.csiro.au/ma/MA14011 […]
AIMED - Let's talk about antibiotics 